Barclays’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Barclays’s Portfolio DOVA Stock Details DOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-24,300	Closed	-$343K	–	7410
2019 Q2	$343K	Buy	+24,300	New	+$231K	﹤0.01%	4665

Barclays's DOVA Position: Q4 2019 in Review

Barclays sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q4 2019, closing a stake of 13,638 shares — an estimated $381K sold.

Barclays first reported a position in DOVA in Q3 2017 and held it in 9 quarters. The position peaked at $653K in Q2 2019. 0 funds tracked by Wall St. Rank hold DOVA as of Q4 2019.

Barclays reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Barclays sold 13,638 Dova Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $381K.
Barclays first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q3 2017 and held it in 9 quarters.
Barclays's Dova Pharmaceuticals, Inc. Common Stock position peaked at $653K in Q2 2019.
0 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.